Glaukos Completes Enrollment in Pivotal U.S. Study of PRESERFLO™ MicroShunt for Advanced Primary Open-Angle Glaucoma Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company dedicated to developing innovative treatments for glaucoma, corneal disorders, and retinal diseases, has announced the successful…
GCCL and GemPharmatech Form Strategic Alliance to Deliver Integrated Drug Discovery and Clinical Development Solutions GCCL, a South Korea-based provider of clinical trial sample analysis and central laboratory services, and GemPharmatech, a global leader in genetically engineered animal models and…
Arrowhead Pharmaceuticals Reports Positive Phase 3 Results for Plozasiran in Severe Hypertriglyceridemia, Demonstrating Significant Triglyceride Reduction and Lower Risk of Acute Pancreatitis Arrowhead Pharmaceuticals, Inc. has announced positive topline results from its pivotal global Phase 3 SHASTA-3 and SHASTA-4 clinical…
Johnson & Johnson Receives FDA De Novo Authorization for OTTAVA™ Robotic Surgical System, Marking a New Era in Robotic-Assisted Surgery Johnson & Johnson has achieved a major milestone in the field of surgical innovation after the U.S. Food and Drug…
Seek Labs Publishes Nature Communications Study Showcasing ANINA™ Technology for Next-Generation Molecular Diagnostics Seek Labs, a private TechBio company focused on developing programmable technologies to decode, understand, and treat disease, has announced the publication of a peer-reviewed research paper in…
Restore Vision and Forge Biologics Partner to Advance RV-001 Gene Therapy for Retinitis Pigmentosa Through Clinical Development Restore Vision, Inc., a clinical-stage biotechnology company focused on developing innovative gene therapies for retinal diseases, has announced a strategic development and manufacturing…
Brenus Pharma Secures €11 Million Series A Extension to Advance Lead Cancer Immunotherapy and Expand Proprietary In Vivo Immunotherapy Platform Brenus Pharma has announced the successful completion of an €11 million ($12.6 million) extension to its Series A financing round,…
DivcoWest Announces Collegium Pharmaceutical as One Lincoln Tenant DivcoWest, a DivCore Capital company and a leading national commercial real estate investment firm, has announced that Collegium Pharmaceutical, a biopharmaceutical company focused on developing innovative medicines for central nervous system (CNS)…
Aptar Pharma Introduces Collaborative System-Level Framework to Advance Injectable Drug Delivery Development Aptar Pharma, a global leader in drug delivery, dosing, protection technologies, and pharmaceutical services, has announced the launch of a new collaborative system-level framework designed to support the…
Mirador Therapeutics Expands Precision Immunology Pipeline Through Global Licensing Agreement for KP-301 Mirador Therapeutics, Inc., a clinical-stage biotechnology company focused on developing precision medicines for immune-mediated inflammatory and fibrotic diseases, has announced a significant expansion of its research and development…
TruTechnologies Unveils New Brand Identity as It Advances Real-Time Clinical Trial Innovation TruTechnologies, a clinical trial software company specializing in real-time visibility into trial execution at the point of care, has introduced a refreshed corporate brand identity alongside the launch…
Zoetis Launches Lenivia® in Europe and Canada to Provide Long-Acting Osteoarthritis Pain Relief for Dogs Zoetis Inc., a global leader in animal health, has announced the commercial launch of Lenivia® (izenivetmab injection) across Canada and European Union member states. The…